FDA Investigator CDR Kimberly Y Martin

CDR Kimberly Y Martin has conducted inspections on 133 sites in 3 countries as of 16 Sep 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
133
Last Inspection Date:
16 Sep 2013
Investigator Role:
FDA Investigator
Redica ID:
100005764
Countries of Inspections:
United States of America, Brazil, Mexico
FDA Investigators that have inspected at least one site in common with CDR Kimberly Y Martin:
Adam J Taylor, Alanna L Mussawwir Bias, Althea A Williams, Amanda L Baskin, Amina Bashir, Andrace L Deyampert, Andrea D Swingle, Angel S Johnson, Ava M Bowman, Barbara A Rusin, Benjamin J Smith, Bernard P Heidt, Brandi N Mcgrady, Brian J Davis, Brian P Hendrickson, Brittany M Lowe, Calvin K Cook, Catherine V Quinlan, Charles E Frelix, Charles M Spyr, Corrine M Carter, Crystal M Young Lewis, Daniel J Gorski, David A Paterson, David L Duncan, Dawn C Olenjack, Debara R Reese, Dennis R Downer, Erma Zaimova, Hans T Meyers, Helen B Ricalde, Ifueko Osemwota, James A Lane, James N Rench, Jeffrey A Sommers, Jennifer L Sheehan, Jennifer R Johnson, John D Jaworski, Joseph R Strelnik, Kelley L Clark, Kimberly A Dux, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Leigh Anne Myers, Lesley Maep Lutao, Lewis K Antwi, Lisa P Oakes, Maira P Brading, Martin K Yau, PhD, Matthew J Gretkierewicz, Megan C Amye, Megan C Spencer, Meisha R Sampson, Meisha Waters, Michael F Skelly, PhD, Misty D Harvey, Myra K Casey, Nancy A Bellamy, Nancy L Neiger, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Nerizza B Guerin, Patricia H Dlugosz, Patrick B Cummings, Rasha Bamieh, Robert M Barbosa, Sam H Haidar, PhD, Seongeun Cho (Julia), PhD, Sherri J Jackson, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stephanie Mangigian, MS/OSH, RN, Susan M North, Theodore N Sietsema, Thursaml, Travis S Bradley, Uttaniti Limchumroon (Tom), Vera M Anderson, William R Brubaker, Xikui Chen (nmi), PhD

CDR Kimberly Y Martin's Documents

Publish Date Document Type Title
April, 2009 FDA 483 Mathew S. Johnson, M.D. - Form 483, 2009-04-08
April, 2010 FDA 483 COVANCE BIOANALYTICAL SERVICES, LLC - Form 483, 2010-04-16
November, 2008 FDA 483 Marcia L. Shew, M.D. - Form 483, 2008-11-17
November, 2008 EIR Marcia L. Shew, M.D. - EIR, 2008-11-17
April, 2009 FDA 483 Response Mathew S. Johnson, M.D. - Form 483R, 2009-05-18
May, 2008 EIR Indiana University Health Ball Memorial Hospital, INC. - EIR, 2008-05-29
August, 2008 EIR Targanta Therapeutics, Corp. - EIR, 2008-08-29
February, 2008 FDA 483 Response Elaine K. Moen, M.D. - Form 483R, 2008-02-22
February, 2008 FDA 483 Elaine K. Moen, M.D. - Form 483, 2008-02-15
September, 2013 FDA 483 Pattanam D. Srinivasan, MD - Form 483, 2013-09-27
February, 2009 EIR Gerardo Gomez, MD - EIR, 2009-02-25
May, 2008 FDA 483 Indiana University Health Ball Memorial Hospital, INC. - Form 483, 2008-05-29
April, 2008 FDA 483 Heartland Laboratory and Andrology Services - Form 483, 2008-03-25
April, 2008 FDA 483 Indiana Fertility Institute - Form 483, 2008-04-11
June, 2009 FDA 483 Versiti Indiana Inc - Form 483, 2009-06-18
April, 2009 FDA 483 James L. Bailen, M.d. - Form 483, 2009-04-24
June, 2008 EIR Marion General Hospital - EIR, 2008-06-12
July, 2009 EIR FirstSource Laboratory Solutions, Inc. - EIR, 2009-07-02
March, 2006 FDA 483 DePuy Indiana - Form 483, 2006-03-02
September, 2013 FDA 483 Response Pattanam D. Srinivasan, MD - Form 483R, 2013-10-18
October, 2005 FDA 483 Response John Brown, MD - Form 483R, 2005-10-28
June, 2008 FDA 483 Marion General Hospital - Form 483, 2008-06-12
August, 2005 FDA 483 Biostorage Technologies, Inc. - Form 483, 2005-08-26
August, 2005 EIR Biostorage Technologies, Inc. - EIR, 2005-08-26
April, 2009 EIR Mathew S. Johnson, M.D. - EIR, 2009-04-08
September, 2013 EIR Pattanam D. Srinivasan, MD - EIR, 2013-09-27
February, 2008 EIR Elaine K. Moen, M.D. - EIR, 2008-02-15
January, 2009 EIR Biostorage Technologies, Inc. - EIR, 2009-01-14
October, 2005 EIR John Brown, MD - EIR, 2005-10-11
October, 2008 EIR Indiana University Health - EIR, 2008-10-30
October, 2005 FDA 483 John Brown, MD - Form 483, 2005-10-11
August, 2008 FDA 483 Targanta Therapeutics, Corp. - Form 483, 2008-08-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more